Stryker (SYK) Cash & Equivalents Growth (1y) (2010 - 2026)
Stryker (SYK) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 72.43% |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn | -26.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.78% |
| Mar 31, 2026 | 24.05% |
| Dec 31, 2025 | 9.83% |
| Sep 30, 2025 | -15.43% |
| Jun 30, 2025 | 26.73% |
| Mar 31, 2025 | -0.43% |
| Dec 31, 2024 | 22.92% |
| Sep 30, 2024 | 106.99% |
| Jun 30, 2024 | 33.76% |
| Mar 31, 2024 | 39.44% |
| Dec 31, 2023 | 61.12% |
| Sep 30, 2023 | 30.99% |
| Jun 30, 2023 | 34.20% |
| Mar 31, 2023 | 14.61% |
| Dec 31, 2022 | -37.36% |
| Sep 30, 2022 | -44.60% |
| Jun 30, 2022 | -53.41% |
| Mar 31, 2022 | -34.85% |
| Dec 31, 2021 | 0.03% |
| Sep 30, 2021 | -63.81% |